Get access

Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production

Authors

  • Hae-Ok Byun,

    1. Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, South Korea
    Search for more papers by this author
  • Hee Young Kim,

    1. Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, South Korea
    Search for more papers by this author
  • Jin J. Lim,

    1. Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, South Korea
    Search for more papers by this author
  • Yong-Hak Seo,

    1. Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, South Korea
    2. Department of Molecular Science & Technology (BK21), The Graduate School, Ajou University, Suwon 443-721, South Korea
    Search for more papers by this author
  • Gyesoon Yoon

    Corresponding author
    1. Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, South Korea
    2. Department of Molecular Science & Technology (BK21), The Graduate School, Ajou University, Suwon 443-721, South Korea
    • San 5, Wonchon-dong, Yongtong-gu, Suwon 443-721, South Korea.
    Search for more papers by this author

  • Hae-Ok Byun and Hee Young Kim contributed equally to this work.

Abstract

Mitochondrial complex II defect has recently been implicated in cellular senescence and in the ageing process of which a critical phenotype is retardation and arrest of cellular growth. However, the underlying mechanisms of how complex II defect affects cellular growth, remain unclear. In this study, we investigated the effect of complex II inhibition using a subcytotoxic dose (400 µM) of 2-thenoyltrifluoroacetone (TTFA), a conventional complex II inhibitor, on cell cycle progression. TTFA (400 µM) directly decreased KCN-sensitive cellular respiration rate to 67% of control and disrupted the mitochondrial membrane potential. In contrast to other respiratory inhibitors such as rotenone, antimycin A, and oligomycin, TTFA prolonged the duration of each phase of the cell cycle (G1, S, and G2/M) equally, thereby delaying overall cell cycle progression. This delay was accompanied by a biphasic increase of reactive oxygen species (ROS) and concurrent glutathione oxidation, in addition to a slight decrease in the cellular ATP level. Finally, the delay in cell cycle progression caused by TTFA was proved to be mainly due to ROS overproduction and subsequent oxidative stress, as evidenced by its reversal following pretreatment with antioxidants. Taken together, these results suggest that an overall delay in cell cycle progression due to complex II defects may contribute to ageing and degenerative diseases via inhibition of cellular growth and proliferation without arrest at any specific phase of the cell cycle. J. Cell. Biochem. 104: 1747–1759, 2008. © 2008 Wiley-Liss, Inc.

Ancillary